Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94

被引:46
|
作者
Wearsch, PA [1 ]
Voglino, L [1 ]
Nicchitta, CV [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
关键词
D O I
10.1021/bi9801006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GRP94, the endoplasmic reticulum Hsp90 paralog, binds a diverse array of peptides, a subset of which are suitable for assembly onto nascent MHC class I molecules. At present, the mechanism, site, and regulation of peptide binding to GRP94 are unknown. Using VSV8, the immunodominant peptide epitope of the vesicular stomatitis virus, and native, purified GRP94, we have investigated GRP94-peptide complex formation. The formation of stable GRP94-VSV8 complexes was slow; competition studies demonstrated that peptide binding to GRP94 was specific. VSV8 binding to GRP94 was stimulated 2-fold or 4-fold, respectively, following chemical denaturation/renaturation or transient heat shock. The activation of GRP94-peptide binding occurred coincident with a stable, tertiary conformational change, as identified by tryptophan fluorescence and proteolysis studies. Analysis of GRP94 secondary structure by circular dichroism spectroscopy indicated an identical alpha-helical content for the native, chemically denatured/renatured, and heat-shocked forms of GRP94. Through use of the environment-sensitive fluorophores acrylodan and Nile Red, it was observed that the activation of peptide binding was accompanied by enhanced peptide and solvent accessibility to a hydrophobic binding site(s). Peptide binding to native or activated GRP94 was identical in the presence or absence of ATP or ADP. These results are discussed with respect to a model in which peptide binding to GRP94 occurs within a hydrophobic binding pocket whose accessibility is conformationally regulated in an adenine nucleotide-independent manner.
引用
收藏
页码:5709 / 5719
页数:11
相关论文
共 50 条
  • [21] Polycystin-1 dependent regulation of polycystin-2 via GRP94, a member of HSP90 family that resides in the endoplasmic reticulum
    Yao, Qin
    Outeda, Patricia
    Xu, Hangxue
    Walker, Rebecca
    Basquin, Denis
    Qian, Feng
    Cebotaru, Liudmila
    Watnick, Terry
    Cebotaru, Valeriu
    FASEB JOURNAL, 2021, 35 (10):
  • [22] Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94 I. Evidence for allosteric regulation of ligand binding
    Rosser, MFN
    Nicchitta, CV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) : 22798 - 22805
  • [23] Endoplasmic reticulum chaperone GRP94 subunit assembly is regulated through a defined oligomerization domain
    Wearsch, PA
    Nicchitta, CV
    BIOCHEMISTRY, 1996, 35 (51) : 16760 - 16769
  • [24] The two faces of GRP94: a selective chaperone with broad peptide binding activity
    Argon, Y
    Wanderling, S
    Simen, B
    Ostrovsky, O
    Biswas, C
    Gidalevitz, T
    IMMUNOLOGY, 2005, 114 (01) : 141 - 141
  • [25] Structural and energetic insight into the isoform-selective inhibitors of tumour marker Hsp90 against Grp94
    Sha, Kun
    Cao, Wei
    MOLECULAR SIMULATION, 2015, 41 (18) : 1553 - 1561
  • [26] Conformational Cycling within the Closed State of Grp94, an Hsp90-Family Chaperone
    Huang, Bin
    Friedman, Larry J.
    Sun, Ming
    Gelles, Jeff
    Street, Timothy O.
    JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (17) : 3312 - 3323
  • [27] Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2
    Xu, WP
    Mimnaugh, EG
    Kim, JS
    Trepel, JB
    Neckers, LM
    CELL STRESS & CHAPERONES, 2002, 7 (01): : 91 - 96
  • [28] Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design
    Immormino, Robert M.
    Metzger, Louis E.
    Reardon, Patrick N.
    Dollins, D. Eric
    Blagg, Brian S. J.
    Gewirth, Daniel T.
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 388 (05) : 1033 - 1042
  • [29] Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance
    Wang, Q
    He, ZZ
    Zhang, JH
    Wang, YY
    Wang, T
    Tong, SP
    Wang, LJ
    Wang, SJ
    Chen, YH
    CANCER DETECTION AND PREVENTION, 2005, 29 (06): : 544 - 551
  • [30] Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
    Park, Hye-Kyung
    Yoon, Nam Gu
    Lee, Ji-Eun
    Hu, Sung
    Yoon, Sora
    Kim, So Yeon
    Hong, Jun-Hee
    Nam, Dougu
    Chae, Young Chan
    Park, Jong Bae
    Kang, Byoung Heon
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (01): : 79 - 91